Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3118 studies found for:    hepatitis
Show Display Options
Rank Status Study
1 Completed
Has Results
The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B Vaccines
Condition: Hepatitis b
Interventions: Biological: 60mcg/1.0ml recombinant hepatitis B vaccine;   Biological: 30mcg/1.0ml recombinant hepatitis B vaccine;   Biological: 10mcg/1.0ml recombinant hepatitis B vaccine
2 Completed HIV and Hepatitis Care Coordination in Methadone Treatment
Conditions: Hepatitis, Viral, Human;   HIV Infections
Interventions: Behavioral: Testing, Education, & Counseling (TEC);   Behavioral: Hepatitis Care Coordination (HCC)
3 Completed Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine
Condition: Hepatitis B
Interventions: Biological: 3 dose of 10µg/0.5ml hepatitis B vaccine;   Biological: 3 dose of 5µg/0.5ml hepatitis B vaccine
4 Active, not recruiting Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients
Conditions: Chronic Kidney Disease;   Hepatitis B
Interventions: Biological: Sci-B-Vac Hepatitis B Vaccine;   Biological: Engerix B  Hepatitis B Vaccine
5 Recruiting Randomized,Paralleled-group Clinical Trial of Hepatitis B Vaccine With Different Doses and Schedules in Healthy Adults
Condition: Hepatitis B
Intervention: Biological: Hepatitis B vaccine
6 Completed
Has Results
Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine
Condition: Hepatitis B
Interventions: Biological: Engerix-B™;   Biological: Fendrix™;   Biological: GSK Biologicals' Hepatitis B vaccines (GSK223192A);   Biological: HBsAg (Booster injection)
7 Completed
Has Results
Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)
Condition: Hepatitis B Virus Infection
Interventions: Biological: Comparator: modified process hepatitis B vaccine;   Biological: Comparator: ENGERIX-B™
8 Completed Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Condition: Hepatitis B Virus (HBV) Associated Liver Disease.
Intervention: Biological: Hepatitis B Immune Globulin (Boca HBVIg)
9 Completed
Has Results
Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068)
Condition: Hepatitis A Virus
Interventions: Biological: Comparator: VAQTA™;   Biological: Comparator: Infanrix™;   Biological: Comparator: PedvaxHIB™
10 Completed
Has Results
A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants
Condition: Hepatitis B
Interventions: Biological: Modified Process Hepatitis B Vaccine (Experimental);   Biological: Hepatitis B Vaccine (Recombinant);   Biological: Comparator: ENGERIX-B
11 Completed
Has Results
Hepatitis B Vaccine Booster Study (V232-058)
Condition: Hepatitis B
Interventions: Biological: Comparator: Modified Process Hepatitis B Vaccine;   Biological: Comparator: Comparator: ENGERIX-B
12 Recruiting De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation
Condition: De Novo Autoimmune Hepatitis
Interventions: Other: Pediatric transplant subject with d-AIH;   Other: Pediatric transplant subject with acute rejection;   Other: Pediatric transplant subject with chronic rejection;   Other: Adult non-transplant patients with auto-immune hepatitis;   Other: Adult non-transplant subjects with chronic hepatitis C virus;   Other: Pediatric control subjects;   Other: Adult transplanted subjects with de novo autoimmune hepatitis
13 Completed
Has Results
The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
14 Active, not recruiting Clinical Trial of Recombinant Hepatitis E Vaccine
Condition: Hepatitis E
Interventions: Biological: hepatitis E vaccine;   Biological: Hepatitis B vaccine
15 Completed
Has Results
Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth
Conditions: HIV Infection;   Hepatitis B
Interventions: Biological: Engerix-B 20 mcg;   Biological: Engerix-B 40 mcg;   Biological: Twinrix 720 EIA HAV Ag plus 20 mcg HBsAg
16 Completed A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)
Condition: Hepatitis B Infection
Interventions: Biological: V232 Modified Process Hepatitis B Vaccine: Lot A;   Biological: V232 Modified Process Hepatitis B Vaccine: Lot B;   Biological: V232 Modified Process Hepatitis B Vaccine: Lot C;   Biological: V232 Current Process Hepatitis B Vaccine
17 Completed
Has Results
Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)
Condition: Hepatitis A Virus
Interventions: Biological: Comparator: VAQTA™ (Hepatitis A vaccine);   Biological: Comparator: ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine);   Biological: Comparator: Prevnar™ (Pneumococcal 7-Valent Conjugate vaccine)
18 Completed
Has Results
LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers
Condition: Hepatitis B
Interventions: Biological: Engerix™ -B;   Biological: Hepatitis B immunoglobulin (HBIg)
19 Completed
Has Results
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule
Conditions: Hepatitis B;   Hepatitis A
Intervention: Biological: Twinrix™ adult
20 Not yet recruiting PCV13 + Hepatitis A Vaccine for Adults
Conditions: Measurement of Immune Response to Prevenar13;   Measurement of Immune Response to Hepatitis A
Interventions: Biological: Prevenar13;   Biological: Hepatitis A vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years